Enhancement of docetaxel solubility using binary and ternary solid dispersion systems

Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability

(2014) Marique Aucamp et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Solubility and dissolution enhancement strategies: current understanding and recent trends

(2014) Shashank Jain et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Docetaxel epimerization in silicone films: a case of drug excipient incompatibility

(2014) Shaikh Mohsin et al.   Drug Testing and Analysis

In Vitro and In Vivo Evaluation of Amorphous Solid Dispersions Generated by Different Bench-Scale Processes, Using Griseofulvin as a Model Compound

(2013) Po-Chang Chiang et al.   AAPS Journal

Data mining of solubility parameters for computational prediction of drug–excipient miscibility

(2013) Amjad Alhalaweh et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions

(2013) Chen Chen et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Evaluation of different screening methods to understand the dissolution behaviors of amorphous solid dispersions

(2013) Thomas Wai-Yip Lee et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Prediction of Drug–Polymer Miscibility through the use of Solubility Parameter based Flory–Huggins Interaction Parameter and the Experimental Validation: PEG as Model Polymer

(2013) Seema Thakral et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Vapor-Induced Phase Transformations in Docetaxel

(2012) Lakshmi Kumar Tatini et al.   AAPS PHARMSCITECH

Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel

(2012) Jian Wu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: Itraconazole

(2012) Thomas Taupitz et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation

(2012) Rehab N. Shamma et al.   POWDER TECHNOLOGY

Influence of polymer chemistry on crystal growth inhibition of two chemically diverse organic molecules

(2011) Umesh S. Kestur et al.   CRYSTENGCOMM

Bivalent sequential binding of docetaxel to methyl-β-cyclodextrin

(2011) Silvia Mazzaferro et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)

(2011) J.J. Moes et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Solid Dispersion as an Approach for Bioavailability Enhancement of Poorly Water-Soluble Drug Ritonavir

(2010) Shilpi Sinha et al.   AAPS PHARMSCITECH

Absence of Both Cytochrome P450 3A and P-glycoprotein Dramatically Increases Docetaxel Oral Bioavailability and Risk of Intestinal Toxicity

(2009) R. A.B. van Waterschoot et al.   CANCER RESEARCH

Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?

(2009) Joachim Brouwers et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Preparation, Characterization and In Vitro Evaluation of Solid Dispersions Containing Docetaxel

(2008) Jie Chen et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Preparation and Characterization of a Submicron Lipid Emulsion of Docetaxel: Submicron Lipid Emulsion of Docetaxel

(2008) Kun Gao et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY